Masimo Corporation’s Q1 2026 filing confirms its focus on healthcare monitoring technologies powered by integrated hardware-software platforms such as Masimo Hospital Automation™ and SafetyNet®. The company operates a single healthcare segment, having divested non-healthcare consumer products, with revenue driven by deferred equipment agreements and multi-year sensor purchase commitments. In early May 2026, shareholders approved a pending acquisition by Danaher Corporation expected to reshape Masimo’s market positioning. Despite merger-related expenses, Masimo maintains robust liquidity (current ratio 2.68) and zero net debt, underpinning operational resilience. The firm’s moat stems from proprietary sensor technology, recurring revenue contracts, and telehealth integration, but contract complexity and regulatory approvals remain watchpoints.